Aprea Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3 | $1 |
Gross Profit | -5 | 4,382 | -3 | |
EBITDA | -3,585 | -3,282 | -2,450 | -2,966 |
EBIT | -3,591 | -3,287 | -2,455 | -2,972 |
Net Income | -3,591 | -3,287 | -2,455 | -2,972 |
Net Change In Cash | 0 | 0 | 3 | 1 |
Free Cash Flow | -3,294 | -2,756 | -2,961 | -3,171 |
Cash | 41,233 | 46,466 | 14,599 | 13,718 |
Basic Shares | 53,483 | 7,687 | 7,687 | 6,372 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $285 | $1,502 | $583 | $0 |
Gross Profit | 264 | -7,860 | 576 | -16,402 |
EBITDA | -12,577 | -12,936 | -14,279 | -37,367 |
EBIT | -12,599 | -12,958 | -14,286 | -37,372 |
Net Income | -12,599 | -12,958 | -14,286 | -112,662 |
Net Change In Cash | 285 | 1,502 | 583 | 0 |
Free Cash Flow | -12,894 | -13,572 | -12,270 | -25,011 |
Cash | 14,599 | 22,849 | 21,606 | 28,786 |
Basic Shares | 6,538 | 5,509 | 3,617 | 82 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.07 |
2026-03-31 | -$0.22 |
2025-12-31 | -$0.32 |
2025-09-30 | -$0.47 |